Retroscreen Medical Director attends XVII International Symposium on Respiratory Viral Infections, Canada 2015

March 3, 2015 1:40 pm

Vancouver, British Colombia, Canada, March 2015

Leading human challenge model research company, Retroscreen Virology, is pleased to announce Medical Director, Dr Anthony Gilbert’s active participation and attendance at “The XVII International Symposium on Respiratory Viral Infections” in Vancouver, Canada, 6 – 8 March 2015.

Organised by The Macrae Foundation, the symposium brings together international thought leaders, performing visionary research and developing current treatments that benefit everyone in the health science field.

Dr Gilbert will be displaying 3 Retroscreen poster presentations: “Using the Human Viral Challenge Model to design subsequent field-based studies”, “The Human Viral Challenge Model in Accelerating Drug Development against RSV”, and “Assays and Mucosal Immunity for Flu and other respiratory viruses”.

The symposium serves as a catalyst for discussing and debating cutting edge information, with the aim of creating an interconnected flow of worldwide research and propelling new directions in research for science, industry and government funding agencies. This Symposium will present the practical aspects of current treatment and future prospects for respiratory viral infectious diseases through invited talks, oral abstracts and poster abstract presentations

Dr Gilbert commented on the symposium: “I am really pleased to have an involvement in this years’ event. As well as the opportunity to illustrate work using our hVIVO human challenge model as poster presentations, we are also delighted that there are other speakers during the three days talking about research programmes that also involved the use of the hVIVO challenge model.”

Retroscreen specialises in providing human viral challenge clinical services to third party study sponsors, helping to accelerate drug and vaccine development. Retroscreen is pioneering a research and technology platform called hVIVO which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled clinical environment.

If you would like to make contact with Dr Gilbert at the event, or if you have a general interest in finding out more about our work, please contact us at  .

To find out more about Retroscreen and hVIVO, check out this website.

To find out more about the symposium, visit

Notes to editors:

Retroscreen has established itself as a world leader in this field through the provision of clinical research services to third party sponsors. The platform has a much wider application in helping to better understand illness because the best way to understand human disease is by studying it in humans, not laboratory models. Since its inception, Retroscreen has successfully carried out over 40 clinical studies, involving more than 85 quarantines and in excess of 1,900 volunteers for a cross-section of leading industry, governmental and academic clients.

Comments are closed here.